Aberdeen Group’s Harpoon Therapeutics HARP Stock Holding History
Bought
Maintained
Sold
Aberdeen Group's HARP Position: Q1 2024 in Review
Aberdeen Group sold out of Harpoon Therapeutics (HARP) in Q1 2024, closing a stake of 25,991 shares — an estimated $296K sold.
Aberdeen Group first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $296K in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.
- Aberdeen Group reported no remaining Harpoon Therapeutics position as of Q1 2024 after selling out during the quarter.
- Aberdeen Group sold 25,991 Harpoon Therapeutics shares in Q1 2024, an estimated $296K.
- Aberdeen Group first reported a position in Harpoon Therapeutics in Q4 2023 and held it in 1 quarter.
- Aberdeen Group's Harpoon Therapeutics position peaked at $296K in Q4 2023.
- 0 funds tracked by Wall St. Rank held Harpoon Therapeutics as of Q1 2024.
Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.